4.5 Article

Long-term dietary habits and interventions in solid-organ transplantation

Journal

JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 34, Issue 11, Pages 1357-1365

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2015.06.014

Keywords

diet; intervention; solid-organ transplantation; long-term dietary habits; nutritional support

Funding

  1. National Institutes of Health and Office of Dietary Supplements [R01HL103931, P20HL113452]

Ask authors/readers for more resources

Diet and nutrition are moving to the forefront of modern primary and preventive care to help address the rising burden of chronic diseases among the general population. Such a movement has yet to occur formally across the field of transplantation. We therefore looked to establish the current base of knowledge regarding diet, nutrition and solid-organ transplantation. A limited number of focused studies looking into the dietary habits of solid-organ transplant patients have been performed and many of the available studies have detailed the nutritional status in the pen-operative period. Frequently described, however, is the heavy incidence of metabolic abnormalities, such as obesity, dyslipidemia and diabetes, occurring after solid-organ transplantation. Optimistically, several studies have noted improvement in several metabolic abnormalities with the use of dietary interventions in the post-transplant period. Despite these positive results, few consensus guidelines for post-transplant diet have been established and nutritional support among transplant programs remains limited. Although there are many hurdles to implementation of detailed dietary recommendations and nutritional support for transplant patients, creating such programs and guidelines could dramatically impact long-term outcomes and burden of chronic metabolic disease for transplant recipients. (C) 2015 International Society for Heart and Lung Transplantation. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information

Joshua Saef, Trejeeve Martyn, Lauren Ives, Lori R. Roth, Justin L. Grodin, Mathew S. Maurer, Mazen Hanna, W. H. Wilson Tang

Summary: Using age, sex, and race as factors, it is possible to accurately determine whether patients with ATTR-CM carry pathogenic TTR gene mutations. Non-Black patients aged 69 years and older diagnosed with ATTR-CM have a low likelihood of having ATTRv.

CIRCULATION-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis

Pieter Martens, Sanjeeb Bhattacharya, Joshua Longinow, Lauren Ives, Miriam Jacob, Jason Valent, Mazen Hanna, W. H. Wilson Tang

Summary: This study analyzed the prognostic relevance of cardiac hemodynamic cutoffs in cardiac amyloidosis (CA) and its subtypes. The results showed that the classic hemodynamic cutoff values were not effective in identifying adverse outcomes, but higher values performed better. Reduced cardiac index was strongly associated with adverse outcomes and independently predicted risk. The study suggested that hemodynamic variables are abnormal in CA, and elevated filling pressures at higher threshold values are prognostic.

CIRCULATION-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Negative Predictive Value and Prognostic Associations of Rb-82 PET/CT with Myocardial Blood Flow in CAV

Bryan Q. Abadie, Nicholas Chan, Zarina Sharalaya, Pavan Bhat, Serge Harb, Miriam Jacob, Randall C. Starling, W. H. Wilson Tang, Paul C. Cremer, Wael A. Jaber

Summary: This study validates the diagnostic and prognostic value of an algorithm using PET/CT scanning with myocardial blood flow (MBF) for cardiac allograft vasculopathy (CAV). PET CAV 0 has a high negative predictive value for moderate to severe CAV, while PET CAV 2/3 has a high positive predictive value. PET/CT scanning with MBF is a reasonable alternative to invasive coronary angiography for CAV screening.

JACC-HEART FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression

W. H. Wilson Tang, Weili Zheng

CIRCULATION-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications

Pieter Martens, Shilin Yu, Brett Larive, Barry A. Borlaug, Serpil C. Erzurum, Samar Farha, J. Emanuel Finet, Gabriele Grunig, Anna R. Hemnes, Nicholas S. Hill, Evelyn M. Horn, Miriam Jacob, Deborah H. Kwon, Margaret M. Park, Franz P. Rischard, Erika B. Rosenzweig, Jennifer D. Wilcox, Wai Hong Wilson Tang

Summary: Iron deficiency is common in pulmonary hypertension, but its clinical significance and optimal definition remain unclear. This study analyzed data from 1028 patients and found that the heart failure definition of iron deficiency endorsed by pulmonary hypertension guidelines did not identify patients with lower exercise capacity or functional status. However, defining iron deficiency as transferrin saturation (TSAT) <21% identified patients with lower exercise capacity, worse functional status, right heart remodeling, and adverse clinical outcomes.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study

Robert A. Montgomery, Joseph Mauch, Parvathy Sankar, Trejeeve Martyn, Tim Engelman, Pieter Martens, Kathleen Faulkenberg, Venu Menon, Jerry D. Estep, W. h. Wilson Tang

Summary: This study compared the safety and efficacy of oral sodium chloride versus placebo during intravenous diuretic therapy in patients with acute heart failure. The results showed no significant difference between the two groups in terms of improving renal function and weight.

JOURNAL OF CARDIAC FAILURE (2023)

Review Cardiac & Cardiovascular Systems

Gut Microbiome-Based Management of Patients With Heart Failure JACC Review Topic of the Week

Petra Mamic, Michael Snyder, W. H. Wilson Tang

Summary: Despite therapeutic advances, chronic heart failure (HF) still poses significant risks. Precision medicine approaches, especially in understanding the role of gut microbiome dysregulation, have the potential to provide novel biomarkers, therapeutic targets, and improved disease risk stratification. Deeper insights into gut microbiome-host interactions may pave the way toward personalized HF care and improved clinical outcomes.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Review Health Care Sciences & Services

Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized Medicine

Sahana Aiyer, Emilia Kalutskaya, Arianne C. Agdamag, W. H. Wilson Tang

Summary: Cardiomyopathy, a leading cause of heart failure, can be caused by abnormalities in the heart muscles that affect its ability to pump blood effectively. Genetic screening and counseling play a crucial role in identifying potential monogenic causes of cardiomyopathy, enabling early intervention and personalized treatment. Cascade testing and risk stratification can help identify at-risk family members and address variants of uncertain significance. This review focuses on the importance of clinical genetic testing for various types of cardiomyopathies, early detection and treatment, family screening, personalized treatment approaches, and current strategies for genetic testing outreach.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis

Erika Hutt, Maria Vega Brizneda, Ghazaleh Goldar, Jose Aguilera, Tom Kai Ming Wang, Ziad Taimeh, Daniel Culver, Thomas Callahan, W. H. Wilson Tang, Paul C. Cremer, Wael A. Jaber, Manuel L. Ribeiro Neto, Christine L. Jellis

Summary: In patients with cardiac sarcoidosis, a mild reduction in left ventricular ejection fraction (LVEF) of 42% was identified as the optimal cutoff for predicting ventricular arrhythmia (VA) and all-cause mortality. Prior occurrence of VA and the presence of scar in cardiac magnetic resonance (CMR) or positron emission tomography (PET) are strong risk factors for future VA and mortality.

EUROPACE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Multiomics Insights to Accelerate Drug Development Will They Hold Their Promises?

W. H. Wilson Tang, Wolfgang Koenig

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Diagnostic Approach for Suspected Acute Myocarditis: Considerations for Standardization and Broadening Clinical Spectrum

Pieter Martens, Leslie T. Cooper, W. H. Wilson Tang

Summary: Myocarditis is most commonly recognized in patients with moderate to severe, recent-onset heart failure. However, less typical presentations including myocardial infarction with normal coronary arteries and arrhythmias are important but less commonly recognized manifestations of myocarditis. Identifying the risk and providing appropriate follow-up and management is crucial in myocarditis.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Prognostic Value of Natriuretic Peptide Levels for Adverse Renal Outcomes in Patients With Moderate to Severe Acute Kidney Injury With or Without Heart Failure

Thanat Chaikijurajai, Sevag Demirjian, W. H. Wilson Tang

Summary: This study aimed to investigate the association between increased baseline NT-proBNP levels and adverse renal outcomes in patients with moderate-to-severe acute kidney injury. The results showed that increased NT-proBNP levels were associated with an increased risk of dialysis requirement, becoming dialysis dependent, and in-hospital mortality.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Ketogenic Diet in Heart Failure Fact or Fiction?

Nandan Kodur, Salva Yurista, Valesha Province, Emma Rueth, Christopher Nguyen, W. H. Wilson Tang

JACC-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure

Pieter Martens, Silvio N. Augusto, J. Emanuel Finet, W. H. Wilson Tang

Summary: Noncardiac comorbidities significantly affect exercise capacity and functional status in patients with chronic heart failure, with certain clusters of comorbidities having a more pronounced impact on outcomes. The type and burden of NCCs in HF patients play a crucial role in determining clinical outcomes and the response to aerobic exercise training.

JACC-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Frailty in the Advanced Heart Failure Patient: A Challenging, Neglected, Yet Potentially Modifiable Risk Factor

Brian Hsi, Valesha Province, W. H. Wilson Tang

Summary: The purpose of this review is to emphasize the significance of frailty in the care of patients with advanced heart failure. It discusses the available data for assessing frailty in these patients and the challenges involved in doing so.

CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE (2023)

No Data Available